These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1404131)

  • 1. Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage.
    Greenwald RA; Moak SA; Ramamurthy NS; Golub LM
    J Rheumatol; 1992 Jun; 19(6):927-38. PubMed ID: 1404131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone-metastasizing cancer cells.
    Duivenvoorden WC; Hirte HW; Singh G
    Invasion Metastasis; 1997; 17(6):312-22. PubMed ID: 9949290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of systemic matrix metalloproteinase inhibitors maintains bone mechanical integrity in adjuvant arthritis.
    Zernicke RF; Wohl GR; Greenwald RA; Moak SA; Leng W; Golub LM
    J Rheumatol; 1997 Jul; 24(7):1324-31. PubMed ID: 9228132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenidap and flurbiprofen enhance uptake of matrix metalloproteinase inhibitor 4-dedimethylaminotetracycline in inflamed joints of adjuvant arthritic rats.
    Leung MK; Greenwald RA; Ramamurthy NS; Moak SA; Koszulinski R; Dieudonne D; Golub LM
    J Rheumatol; 1995 Sep; 22(9):1726-31. PubMed ID: 8523353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetracyclines (TCs) inhibit matrix metalloproteinases (MMPs): in vivo effects in arthritic and diabetic rats and new in vitro studies.
    Golub L; Greenwald R; Ramamurthy N; Zucker S; Ramsammy L; McNamara T
    Matrix Suppl; 1992; 1():315-6. PubMed ID: 1480048
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of epiphyseal cartilage collagenase by tetracyclines in low phosphate rickets in rats.
    Greenwald RA; Simonson BG; Moak SA; Rush SW; Ramamurthy NS; Laskin RS; Golub LM
    J Orthop Res; 1988; 6(5):695-703. PubMed ID: 2841440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetracycline inhibition identifies the cellular sources of collagenase in gingival crevicular fluid in different forms of periodontal diseases.
    Suomalainen K; Halinen S; Ingman T; Lindy O; Saari H; Konttinen YT; Golub LM; Sorsa T
    Drugs Exp Clin Res; 1992; 18(3):99-104. PubMed ID: 1425210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymes active in the areas undergoing cartilage resorption during the development of the secondary ossification center in the tibiae of rats aged 0-21 days: II. Two proteinases, gelatinase B and collagenase-3, are implicated in the lysis of collagen fibrils.
    Davoli MA; Lamplugh L; Beauchemin A; Chan K; Mordier S; Mort JS; Murphy G; Docherty AJ; Leblond CP; Lee ER
    Dev Dyn; 2001 Sep; 222(1):71-88. PubMed ID: 11507770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host modulation with tetracyclines and their chemically modified analogues.
    Golub LM; Suomalainen K; Sorsa T
    Curr Opin Dent; 1992 Mar; 2():80-90. PubMed ID: 1325849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nonantimicrobial properties of tetracycline for the treatment of periodontal disease.
    Vernillo AT; Ramamurthy NS; Golub LM; Rifkin BR
    Curr Opin Periodontol; 1994; ():111-8. PubMed ID: 8032451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional sites of chemically modified tetracyclines: inhibition of the oxidative activation of human neutrophil and chicken osteoclast pro-matrix metalloproteinases.
    Sorsa T; Ramamurthy NS; Vernillo AT; Zhang X; Konttinen YT; Rifkin BR; Golub LM
    J Rheumatol; 1998 May; 25(5):975-82. PubMed ID: 9598901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vanadate, an inhibitor of stromelysin and collagenase expression, suppresses collagen induced arthritis.
    Oliver SJ; Firestein GS; Arsenault L; Cruz TF; Cheng TP; Banquerigo ML; Boyle DL; Brahn E
    J Rheumatol; 2007 Sep; 34(9):1802-9. PubMed ID: 17696279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type II collagen-induced arthritis in the diabetic-resistant biobreeding rat: inflammatory and histopathological features of joint pathology and effects of antiinflammatory and antirheumatic drugs on this chronic arthritic process.
    Smith RJ; Sly LM
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1801-13. PubMed ID: 8667252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs).
    Dittmann KH; Lottspeich F; Ries C; Petrides PE
    Exp Hematol; 1995 Feb; 23(2):155-60. PubMed ID: 7828672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary collagen type II C-telopeptide fragments are sensitive markers of matrix metalloproteinase-dependent cartilage degradation in rat adjuvant-induced arthritis.
    De Ceuninck F; Sabatini M; Renoux V; de Nanteuil G; Pastoureau P
    J Rheumatol; 2003 Jul; 30(7):1561-4. PubMed ID: 12858459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of doxycycline reduces collagenase and gelatinase activities in extracts of human osteoarthritic cartilage.
    Smith GN; Yu LP; Brandt KD; Capello WN
    J Rheumatol; 1998 Mar; 25(3):532-5. PubMed ID: 9517776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo effects of naproxen on composition, proteoglycan metabolism, and matrix metalloproteinase activities in canine articular cartilage.
    Ratcliffe A; Azzo W; Saed-Nejad F; Lane N; Rosenwasser MP; Mow VC
    J Orthop Res; 1993 Mar; 11(2):163-71. PubMed ID: 8483029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis.
    Yamada H; Watanabe K; Saito T; Hayashi H; Niitani Y; Kikuchi T; Ito A; Fujikawa K; Lohmander LS
    J Rheumatol; 1999 Mar; 26(3):654-62. PubMed ID: 10090178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local and systemic factors in periodontal disease increase matrix-degrading enzyme activities in rat gingiva: effect of micocycline therapy.
    Chang KM; Ryan ME; Golub LM; Ramamurthy NS; McNamara TF
    Res Commun Mol Pathol Pharmacol; 1996 Mar; 91(3):303-18. PubMed ID: 8829770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IKKbeta inhibition protects against bone and cartilage destruction in a rat model of rheumatoid arthritis.
    Schopf L; Savinainen A; Anderson K; Kujawa J; DuPont M; Silva M; Siebert E; Chandra S; Morgan J; Gangurde P; Wen D; Lane J; Xu Y; Hepperle M; Harriman G; Ocain T; Jaffee B
    Arthritis Rheum; 2006 Oct; 54(10):3163-73. PubMed ID: 17009244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.